We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

134 hedge funds and large institutions have $1.33B invested in Alder Biopharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

47% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 38

8% more capital invested

Capital invested by funds: $1.22B → $1.33B (+$103M)

7% more call options, than puts

Call options by funds: $3.69M | Put options by funds: $3.43M

4% less funds holding

Funds holding: 140 → 134 (-6)

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

Holders
134
Holders Change
-6
Holders Change %
-4.29%
% of All Funds
3.52%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
18
Increased
56
Reduced
38
Closed
23
Calls
$3.69M
Puts
$3.43M
Net Calls
+$251K
Net Calls Change
+$6.63M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$44.4M
2
PHS
PFM Health Sciences
California
+$26.5M
3
JHIU
Janus Henderson Investors US
Colorado
+$21.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$24.2M
2
BBA
Baker Bros. Advisors
New York
-$16.8M
3
AAMU
Amundi Asset Management US
Massachusetts
-$13.7M
4
Morgan Stanley
Morgan Stanley
New York
-$7.64M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
76
UBS Group
Switzerland
$791K -$3.09M -91,249 -79%
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$777K +$101K +2,985 +15%
DekaBank Deutsche Girozentrale
78
DekaBank Deutsche Girozentrale
Germany
$752K +$13.5K +400 +2%
ACH
79
ArrowMark Colorado Holdings
Colorado
$715K – – –
SO
80
STRS Ohio
Ohio
$713K -$71K -2,100 -9%
Allianz Asset Management
81
Allianz Asset Management
Germany
$644K – – –
TRSOTSOK
82
Teachers Retirement System of the State of Kentucky
Kentucky
$613K +$628K +18,570 New
DCM
83
DAFNA Capital Management
California
$595K – – –
Neuberger Berman Group
84
Neuberger Berman Group
New York
$595K +$609K +18,000 New
AP
85
AlpInvest Partners
Netherlands
$569K – – –
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$559K +$7.98K +236 +1%
MLICM
87
Metropolitan Life Insurance Company (MetLife)
New York
$546K – – –
Squarepoint
88
Squarepoint
New York
$459K +$470K +13,900 New
PPA
89
Parametric Portfolio Associates
Washington
$451K +$462K +13,665 New
D.E. Shaw & Co
90
D.E. Shaw & Co
New York
$437K -$30.7K -907 -6%
AIG
91
American International Group
New York
$399K -$710 -21 -0.2%
RJA
92
Raymond James & Associates
Florida
$390K +$13.5K +398 +3%
VOYA Investment Management
93
VOYA Investment Management
Georgia
$347K – – –
TI
94
Trexquant Investment
Connecticut
$337K -$1.45M -42,990 -81%
PM
95
Parametrica Management
Hong Kong
$309K +$317K +9,360 New
QSS
96
Quantitative Systematic Strategies
Florida
$303K +$302K +8,945 New
FO
97
FT Options
Illinois
$288K +$295K +8,716 New
UBS AM
98
UBS AM
Illinois
$287K – – –
Group One Trading
99
Group One Trading
Illinois
$267K -$578K -17,085 -68%
VEA
100
Virtus ETF Advisers
New York
$255K +$261K +7,728 New
2 3
4
5 6

ALDR Hedge Fund Activity: Q4 2015 in Review

134 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q4 2015, worth a combined $1.33B — up 8.4% from $1.22B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ALDR and 18 opened new positions — a net loss of 5 holders — while 38 trimmed existing stakes and 56 added.

The largest buyer was Wellington Management Group, adding an estimated $44.4M. The largest seller was Millennium Management, cutting an estimated $24.2M.

  • 134 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q4 2015, down from 140 in Q3 2015.
  • Funds reported $1.33B of Alder Biopharmaceuticals stock for Q4 2015, up 8.4% quarter-over-quarter.
  • 18 funds opened new Alder Biopharmaceuticals positions in Q4 2015 and 23 closed out, a net change of -5 holders.
  • The largest Alder Biopharmaceuticals buyer in Q4 2015 was Wellington Management Group, an estimated $44.4M added.
  • The largest Alder Biopharmaceuticals seller in Q4 2015 was Millennium Management, an estimated $24.2M sold.

Based on aggregated 13F filings for Q4 2015.